# Humana (HUM) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/HUM
## Company Profile
- Ticker: HUM
- Exchange: NYSE
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 367.24 USD
- Market cap: 38525334120 USD
- Last updated: 2026-08-06
## Business Overview
### Senior-Focused Health Insurance
Humana is a health and wellness company centered on Medicare Advantage and other government-sponsored health plans. Its insurance operations coordinate benefits, provider networks and care programs for seniors and other eligible populations.
### Medicare Advantage Platform
Individual Medicare Advantage is the company’s core membership business. Humana designs plans, manages medical costs and uses customer service and benefit strategies to attract and retain members across a national footprint.
### CenterWell Care Delivery
CenterWell extends Humana into senior primary care, home health and pharmacy services. The care-delivery platform supports more direct clinical engagement with members and can integrate insurance data with pharmacy and provider workflows.
### State-Based Contracts
Humana also participates in Medicaid and other state-based programs. These contracts diversify its government-healthcare exposure and require locally configured networks, care management and administrative capabilities.
## Why The Stock Is Moving

As of Aug 6, 2026, HUM closed up 0.94% at $367.24. No new same-company headline was identified in the current news window.

## Future Catalysts

- Humana’s catalysts are earnings, Medicare Advantage pricing, and utilization trends that determine whether margin pressure improves or worsens. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.

## Recent News
- 2026-07-29 11:00 EST — [Humana Elects Paul Smith and Frederick Crawford to Board of Directors](https://biopharmsignal.com/news/HUM/humana-elects-paul-smith-and-frederick-crawford-to-board-of-directors-3fd96960) — Source: Humana
- 2026-07-29 10:00 EST — [Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance](https://biopharmsignal.com/news/HUM/humana-reports-second-quarter-2026-financial-results-affirms-full-year-2026-adju-a3dc91c3) — Source: Humana
- 2026-06-22 20:30 EST — [Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026](https://biopharmsignal.com/news/HUM/humana-inc-to-release-second-quarter-2026-results-on-july-29-2026-10d8b923) — Source: Humana
- 2026-06-10 20:30 EST — [Humana Announces Agreement to Divest Minority Interest in Gentiva](https://biopharmsignal.com/news/HUM/humana-announces-agreement-to-divest-minority-interest-in-gentiva-8c639230) — Source: Humana
- 2026-04-29 10:00 EST — [Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance](https://biopharmsignal.com/news/HUM/humana-reports-first-quarter-2026-financial-results-affirms-full-year-2026-adjusted-financial-guidance) — Source: Humana